Yahoo Finance

Quoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton

ASHBURN, Va., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan ...
Yahoo Finance

Netherton Syndrome Pipeline: Industry Insights into Global emerging therapies scenario, Leading Pharma Players, Emerging Trends | DelveInsight

Los Angeles, USA, May 13, 2021 (GLOBE NEWSWIRE) -- Netherton Syndrome Pipeline: Industry Insights into Global emerging therapies scenario, Leading Pharma Players, Emerging Trends | DelveInsight ...
Business Insider

NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome

ASHBURN, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- In recognition of Rare Disease Day® 2026, Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) today highlighted the continued growth of its NETHERTON NOW ...
manilatimes

Quoin Pharmaceuticals Launches 'NETHERTON NOW' Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure

Multi-pronged media campaign to raise awareness about the disease and its impact on patients, family members and caregivers. Interactive, stand-alone NETHERTON NOW website launched. Quoin's QRX003 ...